Rising adiposity curbing decline in the incidence of myocardial infarction: 20-year follow-up of British men and women in the Whitehall II cohort. by Hardoon, SL et al.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
CLINICAL RESEARCH
Prevention
Rising adiposity curbing decline in the incidence
of myocardial infarction: 20-year follow-up
of British men and women in the
Whitehall II cohort
Sarah L. Hardoon1*, Richard W. Morris1, Peter H. Whincup2, Martin J. Shipley3,
Annie R. Britton3, Gabriel Masset3, Silvia Stringhini4, Se´verine Sabia4,
Mika Kivimaki3, Archana Singh-Manoux3,4,5, and Eric J. Brunner3
1Department of Primary Care and Population Health, UCL Medical School, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK; 2Division of Community Health
Sciences, St George’s, University of London, UK; 3Department of Epidemiology and Public Health, UCL, London, UK; 4INSERM U1018, Centre for Research in Epidemiology
and Population Health, Hoˆpital Paul Brousse, Villejuif Cedex, France; and 5Centre de Ge´rontologie, Hoˆpital Ste Pe´rine, AP-HP, Paris, France
Received 12 November 2010; revised 9 March 2011; accepted 11 April 2011; online publish-ahead-of-print 8 June 2011
Aims To estimate the contribution of risk factor trends to 20-year declines in myocardial infarction (MI) incidence in British
men and women.
Methods
and results
From 1985 to 2004, 6379 men and 3074 women in the Whitehall II cohort were followed for incident MI and risk
factor trends. Over 20 years, the age–sex-adjusted hazard of MI fell by 74% (95% confidence interval 48–87%), cor-
responding to an average annual decline of 6.5% (3.2–9.7%). Thirty-four per cent (20–76%) of the decline in MI
hazard could be statistically explained by declining non-HDL cholesterol levels, followed by increased HDL choles-
terol (17%, 10–32%), reduced systolic blood pressure (13%, 7–24%), and reduced cigarette smoking prevalence (6%,
2–14%). Increased fruit and vegetable consumption made a non-significant contribution of 7% (21–20%). In com-
bination, these five risk factors explained 56% (34–112%). Rising body mass index (BMI) was counterproductive,
reducing the scale of the decline by 11% (5–23%) in isolation. The MI decline and the impact of the risk factors
appeared similar for men and women.
Conclusion In men and women, over half of the decline in MI risk could be accounted for by favourable risk factor time trends.
The adverse role of BMI emphasizes the importance of addressing the rising population BMI.
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Introduction
Coronary heart disease (CHD) incidence has declined appreciably
in the UK (by almost two-thirds among men in the last 25 years),1
contributing to a substantial fall in CHD mortality.2 However, the
reasons for the decline in CHD incidence are not well understood.
Furthermore, the possible impact of rising adiposity in restraining
the decline remains unknown. Addressing these uncertainties is
important, because despite the declines CHD remains the
leading cause of death in the UK,2 the USA, and other wealthy
countries,2 while control of the emerging CHD epidemic in the
developing world is an increasing priority.3
Although several studies have examined the contribution of risk
factor trends to changes in incidence or mortality in the UK1,4,5
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and in other locations,6– 8 most have used aggregate data sources
and are subject to the limitations of ecological analyses. Few
studies have used individual-level data from single populations.1,6
One previous UK-based investigation assessed major risk factors
only twice and did not include women.1 The aim of this present
analysis was therefore to estimate the contribution of risk factor
trends to recent trends in the incidence of major CHD in the
Whitehall II cohort of British men and women followed over a
period of 20 years, with clinic visits every 5 years.
Methods
The Whitehall II study
The Whitehall II study, described elsewhere,9 recruited 10 308 men
and women, aged 35–55, from 20 civil service departments in
London in 1985–88. At baseline (1985–88), phase 3 (1991–93),
phase 5 (1997–99), and phase 7 (2002–04), the participants com-
pleted clinical examinations and questionnaires on health and lifestyle.
Participants were flagged at the National Health Service Central
Registry, which provided information on the date and cause of
death. Ethical approval for the Whitehall II study was obtained from
the UCL Medical School Committee on the ethics of human research.
Informed consent was obtained from the study participants.
Coronary events
The outcome was a first myocardial infarction (MI, fatal or non-fatal)
between baseline and 2002–04 (end of phase 7) (mean follow-up of 15.4
(SD 4.2) and 9.0 (SD 4.5) years for participants who were censored and
those who experienced the outcome, respectively). Participants who devel-
oped angina (either before baseline or during follow-up) were retained for
analysis. Fatal MI was identified as a record of death with CHD as the under-
lying cause, including sudden death of presumed cardiac origin (international
classification of diseases, ninth revision, codes 410–414). Potential new
cases of non-fatal MI were ascertained by questionnaire items on chest
pain and the physician’s diagnosis of heart attack in all four phases listed
above. Only those cases confirmed according to MONICA criteria using
electrocardiograms, markers of myocardial necrosis, and chest pain
history from the medical records, were included.10
Assessment of risk factors
At each of the three study phases: baseline (1985–88), phase 3 (1991–
93), and phase 5 (1997–99), cigarette smoking status, physical activity
levels, elements of diet, and alcohol consumption were ascertained by
questionnaire, while fasting lipid levels, systolic blood pressure (SBP),
and body mass index (BMI) were obtained from clinical examinations,
using consistent techniques on each occasion.11,12 At baseline, 9065
participants (88%) had no HDL cholesterol measurement, but serum
apolipoprotein-A1 was available for almost 80% of participants.11
Age- and gender-adjusted linear regression of the available HDL data
on apolipoprotein-A1 was used to estimate the relationship between
the two variables and then predict the baseline HDL for those partici-
pants with no data (see Supplementary material online, Appendix 1).
Alcohol consumption in the previous week was measured as units
per week, then categorized as none, within recommended limit for
gender (,21 units for men, ,14 units for women), over rec-
ommended limit, and very heavy (.50 units for men and .35 units
for women). Cigarette smoking categories were non-smoker,
ex-smoker, and current smoker. Dietary data available were usual
milk consumption (categorized as none, whole milk, semi-skimmed,
skimmed and other), usual bread consumption (white, wholemeal,
granary or wheatmeal, other brown bread, other), and usual fruit
and vegetable consumption (less than three times per week, three
to four times per week, five to six times per week, daily, two or
more times per day). Physical activity levels were categorized as low
(,2 h per week of moderate activity and ,1 h of vigorous activity),
high (≥2.5 h per week of moderate activity or .1 h of vigorous
activity), or medium (levels in between low and high).13
Statistical analyses
Cox regression was used to estimate associations between each risk
factor at phase 1 and subsequent MI hazard to justify inclusion in the
main analyses prior to computing attributable proportions. All risk
factors except type of milk were significantly associated (positively or
negatively) with MI hazard. To estimate secular time trends in the risk
factors and in MI, the follow-up for each participant was split into
three consecutive periods, each of approximately 5 years, separated
by the different examination phases: a first period from phase 1 to
phase 3; a second from phase 3 to phase 5, and a third from phase 5
to phase 7. The MI incidence during, and risk factor levels at the start
of, different periods are then compared, adjusting for age and gender,
to assess secular trends over time. In particular, age-adjusted secular
time trends among men and women from phases 1–5 in the risk
factors were estimated from the regression of the risk factor on calen-
dar time (of start of period), in this split data set using generalized esti-
mating equations with robust standard errors to take account of
dependency between repeated measures for each participant.
Poisson models were fitted for percentage change in prevalence of
being a current cigarette smoker, having medium or more physical
activity levels, consuming alcohol over the recommended limit,
usually eating white bread, and usually eating fruit and vegetables
twice or more daily; and linear models for time trend in mean BMI,
SBP, HDL, and non-HDL cholesterol. Cox regression on this split
data set was used to estimate the time trend in the hazard of MI
overall and by gender, again using robust standard errors to account
for dependency between repeated observations for each participant.
Age was used as the underlying time scale, enabling automatic adjust-
ment for age.14 There was no evidence of departure from the pro-
portional hazards assumption of the Cox regression tested using
Schoenfeld residuals.15
The extent to which the secular time trends in each of the risk factors
statistically explained the trend in MI hazard was estimated by the
expression (b02 b1)/b0, where b0 is the coefficient of calendar time
in the Cox model with calendar time as the single covariate and b1 is
the coefficient of calendar time in a Cox model adjusting additionally
for the risk factor(s).16 Bias-corrected bootstrap resampling gave an
approximate 95% confidence interval (CI) for this estimate.17 Squared
terms in the continuous risk factors (BMI, SBP, and HDL and
non-HDL cholesterol) were added to the models to test for non-
linearity; squared-terms for HDL and non-HDL cholesterol were signifi-
cant and so retained in the final models. The above analyses were applied
to men and women combined, adjusting for gender. Further exploratory
analyses were carried out to estimate risk factor contributions to the
decline in MI in men and women separately. Participants missing data
on one or more risk factors in a particular phase were excluded from
that phase and the associated follow-up, but included in other phases.
Participants missing data in all phases were excluded from analyses
altogether. The number of participants included in each phase is given
in Table 1. A P-value of 0.05 was used as the threshold for statistical sig-
nificance and all tests were two-sided. Stata, version 11.1 (Stata Corp.,
College Station, TX, USA), was used for all analyses.
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Results
Time trends in myocardial infarction
incidence
Of the 10 308 participants recruited, 1 had no follow-up data,
35 reported an MI before baseline, and 819 had missing data
on one or more risk factor at all phases and were excluded
from the analysis. The remaining 9453 participants included
6379 (67%) men and 3074 women. A total of 256 first MI
events occurred during 107 892 person-years of follow-up; 208
first MI events occurred among men during 74 474 person-years
of follow-up and 48 first MI events occurred during 33 418
person-years of follow-up among women. There was an
average annual age-sex-adjusted decline in MI hazard over the
course of the follow-up of 6.5% (95% CI 3.2–9.7) corresponding
to a 20-year fall from baseline (1985–88) to 2004 of 74%
(95% CI 48–87). Men experienced a 20-year fall of 73% (95%
CI 42–87) and women experienced a 20-year fall of 82% (95%
CI 25–97). There was no evidence of a gender–time inter-
action (P ¼ 0.7).
Time trends in risk factors
The levels of each risk factor according to age group and study
phase for men and women are shown in Appendix 2 in the Sup-
plementary material online. Favourable time trends occurred in
several risk factors between 1985–88 and 1997–99: adjusting
for age, mean SBP fell, mean non-HDL cholesterol fell, mean
HDL cholesterol rose, prevalence of consumption of fruit and veg-
etables twice or more daily rose (comparable statistically signifi-
cant changes for men and women); cigarette smoking prevalence
fell (statistically significant among women only), and prevalence
of at least moderate physical activity levels fell (statistically signifi-
cant among men only) (Table 2). Bread consumption did not
change among men or women. There were unfavourable increases
in mean BMI and alcohol consumption, adjusting for age.
Role of risk factors trends in myocardial
infarction incidence trends
Four risk factor trends contributed in isolation to the 74% decline in
MI hazard among all participants (Table 3). Percentage contributions
of these risk factors in order of size were: declining non-HDL
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Table 1 Number of participants contributing data in each study phase by age group (participants with complete risk
factor data)
Age group (years)
35–39 40–44 45–49 50–54 55–59 60–64 65–68 All
Men
Number of participants
Phase
1 (1985–88) 1333 1354 928 1048 129 0 0 4792
3 (1991–93) 100 1537 1401 1015 1029 143 0 5225
5 (1997–99) 0 9 783 964 614 653 180 3203
Number of subsequent incident major CHD eventsa
Phase
1 (1985–88) 6 4 9 25 5 49
3 (1991–93) 1 21 12 31 36 6 107
5 (1997–99) 0 4 9 14 21 4 52
Women
Number of participants
Phase
1 (1985–88) 547 562 532 629 99 0 0 2369
3 (1991–93) 45 549 582 487 575 76 0 2314
5 (1997–99) 0 2 291 336 288 289 79 1285
Number of subsequent incident major CHD eventsa
Phase
1 (1985–88) 0 2 3 6 1 12
3 (1991–93) 0 4 1 9 6 2 22
5 (1997–99) 0 0 1 1 8 4 14
aEvents occurring between phases 1 and 3 for participants at phase 1, between phases 3 and 5 for participants at phase 3, and between phase 5 and phase 7 (2002–4) for
participants at phase 5.
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cholesterol 34% (bootstrap 95% CI 20–76), rising HDL cholesterol
17% (bootstrap 95% CI 10–32), declining SBP 13% (bootstrap 95%
CI 7–24), and declining cigarette smoking 6% (bootstrap 95% CI 2–
14). Together, they explained a total of 54% (95%CI 34–105) of the
decline (the upper bound of the CI indicates that the data are consist-
ent at the 95% confidence level with the risk factors explaining a
greater decline than that observed). The contribution of increased
fruit and vegetable consumption did not reach statistical significance
(7%, bootstrap 95% CI 21 to 20), the combined contribution with
the four other risk factors being 56% (bootstrap 95% CI 34–112).
Trends in physical activity, alcohol consumption, and bread con-
sumption had no notable impact. The rise in mean BMI was
adverse, explaining 211% (bootstrap 95% CI 223 to 25) of the
decline in MI hazard in isolation. The proportion of the decline
explained by the risk factors combined reduced from 56 to 48%
(bootstrap 95% CI 27–96) with additional adjustment for the
adverse trend in BMI. This suggests that the MI decline could be
8% greater in the absence of rising BMI.
Considering men and women separately, the relative contri-
butions of each of the risk factors to the MI declines within each
gender were generally similar to each other and to that in the com-
bined analysis (Table 4). Exceptions were that among women,
there was a smaller contribution from HDL cholesterol compared
with SBP and the proportion explained by cigarette smoking was
not significant. Further, among women, a negative impact of BMI
was not as apparent. In secondary analyses considering fatal
events only, results were similar (data not shown).
Discussion
Over 20 years between 1985 and 2004, there was a substantial
decline of 74% in the age-adjusted hazard of first MI among men
and women the Whitehall II cohort. Over half of the MI decline
could be explained by a combination of favourable time trends in
major risk factors, particularly non-HDL cholesterol, HDL choles-
terol, SBP, and cigarette smoking. Rising adiposity had an adverse
impact on the declining trend in MI, such that had other risk
factor trends not occurred, rising BMI may have led to an increase
in MI incidence over the follow-up. The MI decline and the risk
factor contributions were broadly similar for men and women.
Multiple repeated measurements of risk factors, using consistent
techniques for the measurement of the physical factors on each
occasion, are a key strength of this study. We linked risk factor
trends to coronary events at an individual level, thus avoiding the
limitation of ecological analyses predominantly used to study
time trends. Further, this is apparently the first analytical study of
MI trends in a cohort following both men and women. We used
consistent methods to identify MIs throughout the follow-up
period to limit confounding of the estimate of the incidence
trend by changes in diagnostic criteria. Silent MIs were not
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Table 2 Age-adjusted population-averaged time trends in coronary risk factors among men and women over 12 years
from 1985–88 (baseline) to 1997–99 (phase 5)
Risk factor Men Women
Change in mean levels
per annum (95% CI)
P-value Change over 12
years (95% CI)
Change in mean levels
per annum (95% CI)
P-value Change over 12
years (95% CI)
BMI (kg/m2) 0.10 (0.08, 0.11) ,0.001 1.16 (0.99, 1.33) 0.07 (0.03, 0.10) ,0.001 0.78 (0.41, 1.15)
Systolic blood
pressure
(mmHg)
20.35 (20.42, 20.28) ,0.001 24.19 (25.02, 23.35) 20.52 (20.63, 20.41) ,0.001 26.21 (27.52, 24.90)
Non-HDL
cholesterol
(mmol/L)
20.033 (20.038, 20.028) ,0.001 20.40 (20.46, 20.33) 20.047 (20.054, 20.039) ,0.001 20.56 (20.65, 20.47)
HDL cholesterol
(mmol/L)
0.011 (0.009, 0.012) ,0.001 0.13 (0.11, 0.15) 0.006 (0.004, 0.009) ,0.001 0.08 (0.04, 0.11)
% change in prevalence
per annum (95% CI)
P-value % change over 12
years (95% CI)
% change in prevalence
per annum (95% CI)
P-value % change over 12
years (95% CI)
Current smoker 20.80 (21.89, 0.30) 0.2 29.2 (220.4, 3.6) 23.78 (24.94, 22.62) ,0.001 237.1 (245.5, 227.2)
At least moderate
physical activity
21.06 (21.35, 20.76) ,0.001 212.0 (215.1, 28.8) 20.48 (21.16, 0.21) 0.2 25.6 (213.1, 2.5)
Consume alcohol
over
recommended
limit
6.12 (5.15, 7.10) ,0.001 104 (82.8, 128) 7.96 (5.79, 10.17) ,0.001 151 (96.5, 220)
White bread as
usual bread type
20.26 (20.53, 0.01) 0.06 23.1 (26.2, 0.1) 0.12 (20.24, 0.47) 0.5 1.4 (22.8, 5.8)
Consume fruit and
vegetables twice
or more daily
7.99 (7.01, 8.98) ,0.001 151 (125, 180) 8.73 (7.56, 9.92) ,0.001 173 (140, 211)
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included, and the outcome thus corresponds to major CHD
events. Risk factor levels were related to MI events up to 5
years ahead, based on the interval between clinic phases, and
there is evidence that the benefits of smoking cessation, changes
in blood lipids, and blood pressure are realized in this time-
frame.18– 20
There are several limitations. The analyses were necessarily
based on participants who re-attended after baseline and provided
complete risk factor data at one phase at least. This could intro-
duce survival and response biases which might overestimate the
favourable trends observed, due to a healthy participant effect.
However, survivor bias is unlikely to be marked as survival in the
cohort is high.9 Including those participants with missing risk
factor data, the 20-year decline was smaller: 62% (95% CI
34–78) indicating some response bias. As we could arguably
expect similar overestimation of the favourable risk factor trends,
the percentage explained by each risk factor may still be compar-
able. HDL cholesterol values at baseline were derived from serum
apolipoprotein-A1 for a subgroup of the participants. The likely
impact is underestimation of the variance associated with the base-
line HDL measurements but without biasing the estimate of the
contribution of HDL to the MI decline. Any measurement impreci-
sion of the risk factors, particularly likely for the questionnaire-
derived dietary factors, physical activity, and alcohol consumption,
may have led to the underestimation of the contribution to the MI
decline. Questions on physical activity at phase 5 were more
detailed than those in the earlier phases, giving more opportunity
to report activity, which could lead to the underestimation of the
physical activity decline and its counterproductive role. The ana-
lyses of the risk factor contributions by gender lack precision
(CIs for the percentage contributions are wide), particularly for
women who experienced few events (48 in total), and should
thus be considered exploratory. Diabetes was not considered in
this analysis. It is likely that diabetes lies on the causal pathway
between several of the risk factors considered here and
major CHD risk. Including diabetes in the analysis would therefore
be problematic and could lead to the underestimation of the
effects of the risk factors.21 The limitation of not considering dia-
betes is that we are unable to ascertain the extent to which the
adverse effect of increasing BMI levels operates through an
increase in diabetes (particularly type 2 diabetes) incidence.
Effort was made to model carefully the relationship between the
risk factors and MI incidence, for example, by inclusion of
squared terms in the continuous variables in the Cox regression
models, where significant. However, if the relationship between
the risk factors and MI incidence is not fully captured in the Cox
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Table 3 Fall in hazard of a first myocardial infarction per annum among all participants and percentage of this fall
explained by risk factor time trends
Model Risk factors adjusted for in addition to
age and gender
Fall in hazard per
annum, % (95% CI)
P-value % of the observed decline in hazard
explained by the risk factor(s) (95% CI)a
A No adjustment 6.51 (3.22, 9.68) ,0.001
Effect of adjustment for individual risk factors in isolation
B Smoking (current/ex/never) 6.13 (2.82, 9.33) ,0.001 5.9 (2.3, 13.6)
C Physical activity (low/medium/high) 6.51 (3.20, 9.70) ,0.001 0.1 (24.5, 5.3)
D Alcohol units per week (none/within limit/over
limit/heavy)
6.44 (3.13, 9.65) ,0.001 1.0 (26.1, 8.3)
E Usual bread consumption (white/wholemeal/
granary or wheatmeal/other brown bread/
combination)
6.55 (3.26, 9.72) ,0.001 20.6 (23.3, 0.3)
F Usual fruit and vegetable consumption (less
than three times per week/three to four
times per week/five to six times per week/
daily/one or more times per day)
6.07 (2.72, 9.31) ,0.001 6.8 (21.1, 19.9)
G BMI (kg/m2) (continuous) 7.18 (3.94, 10.32) ,0.001 210.8 (223.2, 24.6)
H Systolic blood pressure (mmHg) (continuous) 5.70 (2.41, 8.87) 0.001 12.8 (7.4, 24.4)
I HDL cholesterol (mmol/L) (continuous) 5.45 (2.13, 8.67) 0.001 16.6 (9.9, 32.3)
J Non-HDL cholesterol (mmol/L) (continuous) 4.32 (0.79, 7.72) 0.02 34.4 (20.4, 75.7)
Effect of adjustment for combinations of risk factors
K Smoking, non-HDL cholesterol, HDL
cholesterol, systolic blood pressure
3.05 (20.47, 6.44) 0.09 54.4 (34.4, 105)
L Smoking, non-HDL cholesterol, HDL
cholesterol, systolic blood pressure, usual
fruit and vegetable consumption
2.92 (20.64, 6.36) 0.1 55.9 (34.3, 112)
M Smoking, non-HDL cholesterol, HDL
cholesterol, systolic blood pressure, usual
fruit and vegetable consumption, BMI
3.44 (20.15, 6.91) 0.06 47.9 (26.6, 95.5)
a% of the observed fall in hazard rate explained by risk factor ¼ 100% × (b02 b1)/b0, where b0 is the coefficient of calendar time in the Cox regression model which only
included calendar time (Model A) and b1 is the coefficient of calendar time in the Cox regression model adjusting additionally for the risk factor(s)
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Table 4 Fall in hazard of a first myocardial infarction per annum and percentage of this fall explained by risk factor time
trends among men and women
Model Men Women
Fall in hazard per
annum, % (95%
CI)
P-value % of decline in hazard
explained by risk
factor(s), (95% CI)a
Fall in hazard per
annum, % (95% CI)
P-value % of decline in
hazard explained by
risk factor(s), (95%
CI)a
A No adjustment 6.26 (2.66, 9.73) 0.001 8.12 (20.25, 15.80) 0.06
Effect of adjustment for individual risk factors in isolation
B Smoking (current/ex/
never)
5.96 (2.34, 9.45) 0.001 4.8 (1.4, 13) 7.51 (20.96, 15.27) 0.08 7.9 (23.3, 43.9)
C Physical activity (low/
medium/high)
6.31 (2.70, 9.79) 0.001 20.9 (26.9, 4.7) 7.78 (20.75, 15.58) 0.07 4.5 (23.1, 60.7)
D Alcohol units per week
(none/within limit/
over limit/heavy)
6.25 (2.62, 9.75) 0.001 0.1 (29.2, 9.3) 7.84 (20.64, 15.60) 0.07 3.7 (210.2, 32.6)
E Usual bread
consumption (white/
wholemeal/granary or
wheatmeal/other
brown bread/
combination)
6.29 (2.69, 9.75) 0.001 20.5 (23.8, 0.6) 8.16 (20.26, 15.86) 0.06 20.4 (29.1, 6.4)
F Usual fruit and vegetable
consumption (less
than three times per
week/three to four
times per week/five
to six times per week/
daily/one or more
times per day)
5.87 (2.20, 9.40) 0.002 6.3 (22.2, 23.1) 7.29 (21.32, 15.18) 0.1 10.6 (223.1, 57.3)
G BMI (kg/m2)
(continuous)
7.32 (3.73, 10.77) ,0.001 217.6 (241.1, 28.2) 8.22 (20.06, 15.81) 0.05 21.2 (228.0, 14.2)
H Systolic blood pressure
(mmHg) (continuous)
5.58 (1.98, 9.05) 0.003 11.1 (5.7, 25.5) 6.67 (21.73, 14.37) 0.1 18.5 (6.8, 69.8)
I HDL cholesterol (mmol/
L) (continuous)
5.10 (1.43, 8.62) 0.007 19.1 (10.2, 39.0) 7.48 (20.91, 15.17) 0.08 8.3 (1.0, 44.4)
J Non-HDL cholesterol
(mmol/L)
(continuous)
4.19 (0.32, 7.91) 0.03 33.8 (18.2, 87.4) 5.52 (23.47, 13.73) 0.2 33.0 (10.8, 214)
Effect of adjustment for combinations of risk factors
K Smoking, non-HDL
cholesterol, HDL
cholesterol, systolic
blood pressure
2.99 (20.88, 6.71) 0.1 53.0 (30.7, 123) 3.66 (25.35, 11.89) 0.4 56.0 (21.5, 269)
L Smoking, non-HDL
cholesterol, HDL
cholesterol, systolic
blood pressure, usual
fruit and vegetable
consumption
2.90 (21.02, 6.67) 0.1 54.4 (29.8, 126) 3.38 (25.66, 11.65) 0.5 59.4 (19.2, 221)
M Smoking, non-HDL
cholesterol, HDL
cholesterol, systolic
blood pressure, usual
fruit and vegetable
consumption, BMI
3.48 (20.49, 7.30) 0.09 45.1 (21.7, 119) 3.76 (25.27, 12.02) 0.4 54.7 (11.2, 210)
a% of the observed fall in hazard rate explained by risk factor ¼ 100% × (b02 b1)/b0, where b0 is the coefficient of calendar time in the Cox regression model which only
included calendar time (Model A) and b1 is the coefficient of calendar time in the Cox regression model adjusting additionally for the risk factor(s).
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models, this may have led to the underestimation of the association
between the risk factors and the MI risk and in turn the underes-
timation of the percentage of the decline in MI explained by the
risk factors.
Trends in non-HDL cholesterol had the greatest single impact
on the decline in MI incidence. The favourable time trend
in non-HDL cholesterol may reflect the increasing use of
lipid-regulating medication or lifestyle (e.g. diet) or some combi-
nation of factors. Statin use rose to 11% of the cohort (25% of
those with high LDL cholesterol) by the end of the follow-up in
2004,22 suggesting that lipid-regulating medication may have
made an appreciable contribution.
The combined contribution of the risk factors to the MI decline
in the present study was similar to that found in a national cohort
of men over a similar period (46%), but the individual relative
impacts of the risk factors differed between the two cohorts.1
The decline in smoking prevalence had greater impact in the
national cohort, possibly explained by the already lower preva-
lence of smokers at a later baseline in the present study (23%
among men in Whitehall II compared with 40% among men in
the national cohort). The trend in and contribution of non-HDL
cholesterol was smaller in the national cohort (non-HDL choles-
terol fell by 0.4 mmol/L over 12 years in Whitehall II men, com-
pared with 0.35 mmol/L over 20 years in the national cohort23),
possibly reflecting greater take-up of effective lipid-lowering medi-
cation in the present study.22 The differences may reflect the
higher socioeconomic status in the present London-based
cohort. Indeed, in results stratified by employment grade, the
risk factor contributions in the lowest grades corresponded
more closely to the national cohort findings (data not shown).
In a comparable analysis of US women, 68% of the decline in
CHD incidence could be explained by combined trends in
smoking, diet (decreased saturated fat, increased fibre content),
and post-menopausal hormone use.6 Dietary trends in isolation
accounted for the largest part of the decline (52%). The greater
contribution of diet in the US investigation is likely to reflect the
influence of diet on risk factors such as blood pressure and choles-
terol not available in that study, but included as explanatory vari-
ables in our analysis. Any protective effect of hormone therapy is
doubtful in the light of recent evidence from the Women’s Health
Initiative.24 Finally, the WHO MONICA Project suggested that ciga-
rette smoking, SBP and total cholesterol together explained
approximately 38% of the variation in trends in coronary event
rates from the mid-1980s to the mid-1990s in men in 27 different
populations.7 The lower total percentage explained may reflect
the ecological analysis, using aggregate data to study variations in
trends between populations, rather than studying variation over
time in individuals within one population as in the present study.
Implications
In this cohort of London civil servants, there was a substantial
decline in MI over two decades to 2004, more than half of
which could be attributed to favourable risk factor trends, high-
lighting what can be achieved and emphasizing the value of
measures to reduce exposure to these risk factors in the popu-
lation. The risk factor trends were of comparable importance for
men and women, suggesting that similar influences have operated
to achieve declines in MI incidence, such that similar prevention
strategies may be appropriate for both genders. Further research
is needed to determine whether the residual unexplained
portion of the decline in MI may be explained by early treatment,
underestimated contributions of the major risk factors (reflecting
imprecision in the analyses), or the influence of other risk
factors. The apparent lack of association of the decline in physical
activity with the time trend in MI may reflect the methodological
limitations associated with quantifying activity levels or the
measured decline in the activity levels was insufficient to influence
MI incidence.
While the negative contribution of rising mean BMI over recent
decades appears to have been outweighed by the favourable
trends in other vascular risk factors, continued increases in BMI
may further reduce or even reverse the decline in MI incidence.
The extent to which the rise in BMI may have influenced the
time trend in MI through an increase in the incidence of diabetes
cannot be evaluated from this analysis. The association between
type 2 diabetes and CHD risk is well established and previous
studies suggest that a concurrent rise in incidence of type 2 dia-
betes has occurred which may be at least in part explained by
rising BMI,25 supporting the influence of BMI on the time-trend
in CHD operating to some extent through rising diabetes.
Sharply rising trends in statin and BP-lowering medication2,23 may
contribute to continuing favourable MI incidence trends in the
UK and other rich countries but it is unlikely that the healthcare
systems in emerging economies will have the necessary resources
to provide the level of care needed to compensate for the increas-
ing prevalence of overweight and obesity already taking place. The
rising BMI in the UK and in other countries needs therefore urgent
attention.
Supplementary material
Supplementary material is available at European Heart Journal
online.
Funding
S.L.H. is supported by a Medical Research Council Training Fellowship
in Health Services Research & Health of the Public (G0701739). M.J.S.
is supported by a grant from the British Heart Foundation. The White-
hall II study has been supported by grants from the Medical Research
Council, British Heart Foundation, Health and Safety Executive,
Department of Health, Stroke Association, National Heart Lung and
Blood Institute (HL36310), National Institute on Aging (AG13196)
and Agency for Health Care Policy Research (HS06516), and the
John D and Catherine T MacArthur Foundation. Funding to pay the
Open Access publication charges for this article was provided by the
Medical Research Council.
Conflict of interest: none declared.
References
1. Hardoon SL, Whincup PH, Lennon LT, Wannamethee SG, Capewell S,
Morris RW. How much of the recent decline in the incidence of myocardial
infarction in British men can be explained by changes in cardiovascular risk
factors? Evidence from a prospective population-based study. Circulation 2008;
117:598–604.
2. British Heart Foundation Statistics. http://www.heartstats.org (accessed on June
2009).
S.L. Hardoon et al.484
3. Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K. The burden and
costs of chronic diseases in low-income and middle-income countries. Lancet
2007;370:1929–1938.
4. Capewell S, Morrison CE, McMurray JJ. Contribution of modern cardiovascular
treatment and risk factor changes to the decline in coronary heart disease mor-
tality in Scotland between 1975 and 1994. Heart 1999;81:380–386.
5. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease
mortality in England and Wales between 1981 and 2000. Circulation 2004;109:
1101–1107.
6. Hu FB, Stampfer MJ, Manson JE, Grodstein F, Colditz GA, Speizer FE, Willett WC.
Trends in the incidence of coronary heart disease and changes in diet and lifestyle
in women. N Engl J Med 2000;343:530–537.
7. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H,
Evans A, Ferrario M, Tuomilehto J; for the WHO MONICA Project. Estimation
of contribution of changes in classic risk factors to trends in coronary-event
rates across the WHO MONICA Project populations. Lancet 2000;355:675–687.
8. Wijeysundera HC, Machado M, Farahati F, Wang X, Witteman W, van der Velde G,
Tu JV, Lee DS, Goodman SG, Petrella R, O’Flaherty M, Krahn M, Capewell S.
Association of temporal trends in risk factors and treatment uptake with coronary
heart disease mortality, 1994–2005. JAMA 2010;303:1841–1847.
9. Marmot M, Brunner E. Cohort Profile: the Whitehall II study. Int J Epidemiol 2005;
34:251–256.
10. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A.
Myocardial infarction and coronary deaths in the World Health Organization
MONICA Project. Registration procedures, event rates, and case-fatality rates in
38 populations from 21 countries in four continents. Circulation 1994;90:583–612.
11. Brunner EJ, Marmot MG, White IR, O’Brien JR, Etherington MD, Slavin BM,
Kearney EM, Smith GD. Gender and employment grade differences in blood
cholesterol, apolipoproteins and haemostatic factors in the Whitehall II study.
Atherosclerosis 1993;102:195–207.
12. Brunner EJ, Marmot MG, Nanchahal K, Shipley MJ, Stansfeld SA, Juneja M,
Alberti KG. Social inequality in coronary risk: central obesity and the metabolic
syndrome. Evidence from the Whitehall II study. Diabetologia 1997;40:
1341–1349.
13. Singh-Manoux A, Hillsdon M, Brunner E, Marmot M. Effects of physical activity on
cognitive functioning in middle age: evidence from the Whitehall II prospective
cohort study. Am J Public Health 2005;95:2252–2258.
14. Thiebaut AC, Benichou J. Choice of time-scale in Cox’s model analysis of epide-
miologic cohort data: a simulation study. Stat Med 2004;23:3803–3820.
15. Schoenfeld D. Partial residuals for the proportional hazards regression model.
Biometrika 1982;69:239–241.
16. Freedman LS, Graubard BI, Schatzkin A. Statistical validation of intermediate end-
points for chronic diseases. Stat Med 1992;11:167–178.
17. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. London: Chapman and Hall;
1993.
18. Boutitie F, Gueyffier F, Pocock SJ, Boissel JP. Assessing treatment-time interaction
in clinical trials with time to event data: A meta-analysis of hypertension trials. Stat
Med 1998;17:2883–2903.
19. Dobson AJ, Alexander HM, Heller RF, Lloyd DM. How soon after quitting
smoking does risk of heart attack decline? J Clin Epidemiol 1991;44:1247–1253.
20. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction
in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ
1994;308:367–372.
21. Weinberg CR. Towards a clearer definition of confounding. Am J Epidemiology
1993;137:1–8.
22. Bouillon K, Singh-Manoux A, Jokela M, Shipley MJ, Batty GD, Brunner EJ, Sabia S,
Taba´k AG, Akbaraly T, Ferrie JE, Kivima¨ki M. Decline in low-density lipoprotein
cholesterol concentration: lipid-lowering drugs, diet, or physical activity? Evidence
from the Whitehall II study. Heart; PubMed PMID: 21487128. Published online
ahead of print 12 April 2011.
23. Hardoon SL, Whincup PH, Wannamethee SG, Lennon LT, Capewell S,
Morris RW. Assessing the impact of medication use on trends in major coronary
risk factors in older British men: a cohort study. Eur J Cardiovasc Prev Rehabil 2010;
17:502–508.
24. Prentice RL, Langer RD, Stefanick ML, Howard BV, Pettinger M, Anderson GL,
Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J. Com-
bined analysis of Women’s Health Initiative observational and clinical trial data
on postmenopausal hormone treatment and cardiovascular disease. Am J
Epidemiol 2006;163:589–599.
25. Hardoon SL, Morris RW, Thomas MC, Wannamethee SG, Lennon LT,
Whincup PH. Is the recent rise in Type 2 diabetes incidence from 1984 to
2007 explained by the trend in increasing BMI? Evidence from a prospective
study of British men. Diabetes Care 2010;33:1494–1496.
Rising adiposity curbing decline in the incidence of MI 485
